MedicinesFAQ

EGS21 Uses, Dosage, Side Effects and more

EGS21(TM) is a beta-D-glucosylceramide (GC) compound. It is a potential therapeutic for treating immune mediated disorders. GC is a glycolipid that has been shown by Enzo scientists and collaborators to act as an anti-inflammatory agent in animal model systems, and therefore is being evaluated as an important candidate drug in the treatment of various immune mediated diseases, such as Crohn's disease, hepatitis, non-alcoholic steatohepatitis (NASH) or fatty liver and HIV.

Attribute Details
Trade Name EGS21
Generic EGS21
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in crohn's disease, hepatitis (unspecified), and liver disease.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.